Underwood Capital Limited has released a press release.
MMJ Receives Approval to Conduct MS Phase 2 Clinical Trials
Filed with ASX ·
6ix hasn’t read this filing yet.
Underwood Capital Limited on 6ix
Earlier from Underwood Capital
- Completion of First Shipment of MC Products into Australia
- Harvest One Signs Funding Agreements with PanCann
- Harvest One Listing
- Harvest One Receives Conditional TSX-V Listing Approval
- First Cannabis Crop Harvested at Duncan Facility
Later from Underwood Capital
- Satipharm Patent Application Update
- Commits A$500,000 Cornerstone Investment in eSense-Lab
- MMJ Clinical Trial Results Published in Medical Journal
- Harvest One Financing Update
- Strategic Investment in Weed Me Inc.
Follow Underwood Capital into a list and get an email when it puts out news.
Follow Underwood Capital